Literature DB >> 32733

Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure.

N V Nielsen.   

Abstract

In 43 persons with increased intraocular pressure (IOP) Timolol maleate eye drops (0.25% and 0.5%) were used as a single and combined treatment. A significant decrease in IOP was noticed in 34 persons (P less than 0.001) initially. No diminished effect of treatment was apparent after 9 weeks in 34 subjects or after 15 weeks in 23 subjects with Timolol alone. In nine persons with high IOP, Timolol had a significant (P less than 0.001) but insufficient lowering effect. Epinephrine (1%) and acetazolamide appeared to have an additive effect in these cases. No serious local or systemic adverse effects were discovered.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32733

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  9 in total

1.  Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma.

Authors:  K B Mills
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

2.  [The effect of timolol and parasympathicomimetica in the treatment of the elevated intraocular pressure (author's transl)].

Authors:  M Ober; A Scharrer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-07-02

3.  [Timolol and acetazolamide in the treatment of increased intraocular pressure (author's transl)].

Authors:  A Scharrer; M Ober
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979

4.  The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study.

Authors:  W Leydhecker; G K Krieglstein
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-04-02

Review 5.  Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

6.  Addition of timolol maleate to routine medical therapy: a clinical trial.

Authors:  R J Smith; S Nagasubramanian; R Watkins; D Poinoosawmy
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

7.  The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.

Authors:  K K Takki; A Klemetti; O Valle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

8.  Timolol in operated closed-angle glaucoma.

Authors:  C I Phillips
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

9.  Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.

Authors:  J V Thomas; D L Epstein
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.